CN Patent
CN109280071A — 奥贝胆酸的晶型及其制备方法
Assigned to Dongguan Hec Pharm R&d Co ltd · Expires 2019-01-29 · 7y expired
What this patent protects
本发明涉及奥贝胆酸的晶型及其制备方法,属于医药技术领域。所述晶型为晶型K,晶型K为一水合物,其在一定条件稳定、有利于储存、转移、易于制备,可用于制备药物制剂生产中。
USPTO Abstract
本发明涉及奥贝胆酸的晶型及其制备方法,属于医药技术领域。所述晶型为晶型K,晶型K为一水合物,其在一定条件稳定、有利于储存、转移、易于制备,可用于制备药物制剂生产中。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.